|
1592U89 |
(1S,4R)-4-[2-amino-6-cyclopropyl-amino)-9H-purin-9-yl]-2-cyclopentene-1-methanol succinate (a carbovir analogue, Glaxo Wellcome) |
|
3TC |
(-)-b-L-2',3'-dideoxy-3'-thiacytidine (Glaxo Wellcome) |
|
1737 |
Tetrahydronapthalene lignan derivative |
|
a-APA R18893 |
a-nitro-anilino-phenylacetamide |
|
A-77003, A-75925, A-80987 |
C2 symmetry-based protease inhibitors (Abbott Laboratories) |
|
AAP-BHAP |
bisheteroarylpiperazine analogue (Pharmacia & Upjohn) |
|
ABT-378 |
Protease inhibitor |
|
ABT-538 |
C2 symmetry-based protease inhibitor (Abbott Laboratories) |
|
ADAMII |
Methyl 3',3''-dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-6,6-diphenyl-5-hexenoate. An alkenyldiarylmethane |
|
AZdU |
3'-azido-2',3'-dideoxyuridine |
|
AZT |
3'-azido-3'-deoxythymidine (Glaxo Wellcome) |
|
AZT-p-ddI |
3'-azido-3'-deoxythymidilyl-(5',5')-2',3'-dideoxyinosinic acid (Ivax) |
|
BHAP |
bisheteroarylpiperazine |
|
BILA 1906 |
N-{1S-[[[3-[2S-(1,1-dimethylethyl)amino]carbonyl}-4R-]3-pyridinylmethyl)thio]-1-piperidinyl]-2R-hydroxy-1S-(phenylmethyl)propyl]amino]carbonyl]-2-methylpropyl}-2-quinolinecarboxamide (Bio-Mega/Boehringer Ingelheim) |
|
BILA 2185 |
N-(1,1-dimethylethyl)-1-[2S-[[2-2,6-dimethyphenoxy)-1-oxoethyl]amino]-2R-hydroxy-4-phenylbutyl]4R-pyridinylthio)-2-piperidine-carboxamide (Bio-Mega/Boehringer Ingelheim) |
|
BM+51.0836 |
thiazolo-isoindolinone derivative |
|
BMS 186,318 |
aminodiol derivative HIV-1 protease inhibitor (Bristol-Myers Squibb) |
|
d4API |
9-[2,5-dihydro-5-(phosphonomethoxy)-2-furanel]adenine (Gilead Sciences) |
|
d4C |
2',3'-didehydro-2',3'-dideoxycytidine |
|
d4T |
2',3'-didehydro-3'-deoxythymidine (Bristol-Myers Squibb) |
|
ddC |
2',3'-dideoxycytidine (Roche) |
|
ddI |
2',3'-dideoxyinosine (Bristol-Myers Squibb) |
|
DMP 266 |
a 1,4-dihydro-2H-3,1-benzoxazin-2-one |
|
DMP 450 |
{[4R-(4-a,5-a,6-b,7-b)]-hexahydro-5,6-bis(hydroxy)-1,3-bis(3-amino)phenyl]methyl)-4,7-bis(phenylmethyl)-2{\it H}-1,3-diazepin-2-one}-bismesylate (Avid Therapeutics) |
|
DP178 |
Synthetic peptide containing amino acids 127 to 162 of HIV-1 gp41 |
|
DXG |
(-)-b-D-dioxolane-guanosine |
|
EBU-dM |
5-ethyl-1-ethoxymethyl-6-(3,5-dimethylbenzyl)uracil |
|
E-EBU |
5-ethyl-1-ethoxymethyl-6-benzyluracil |
|
DS |
dextran sulphate |
|
E-EPSeU |
1-(ethoxymethyl)-(6-phenylselenyl)-5-ethyluracil |
|
E-EPU |
1-(ethoxymethyl)-(6-phenyl-thio)-5-ethyluracil |
|
F-ddA |
2'-fluoro-2',3'-dideoxyadenosine |
|
(-)-FTC |
(-)-b-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine (Triangle Pharmaceuticals) |
|
HBY 097 |
(S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthio-methyl)-3,4-dihydroquinoxalin-2(1H)-thione |
|
HEPT |
1-[(2-hydroxyethoxy)methyl]6-(phenylthio)thymine |
|
JM2763 |
1,1'-(1,3-propanediyl)-bis-1,4,8,11-tetraazacyclo-tetradecane (Johnson Matthey) |
|
JM3100 |
1,1'-[1,4-phenylenebis-(methylene)]bis-(1,4,8,11-tetraazacyclotetradecane) octahydrochloride dihydrate (Johnson Matthey) |
|
KNI-272 |
(2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid-containing tripeptide |
|
L-697,593 |
5-ethyl-6-methyl-3-(2-phthalimido-ethyl)pyridin-2(1H)-one |
|
L-697,661 |
3-{[(-4,7-dichloro-1,3-benzoxazol-2-yl)methyl]amino}-5-ethyl-6-methylpyridin-2(1H)-one |
|
L-FDDC |
(-)-b-L-5-fluoro-2',3'-dideoxy-cytidine |
|
L-FDOC |
(-)-b-L-5-fluoro-dioxolane cytosine |
|
MK-639 |
hydroxy-aminopentane amide HIV-1 protease inhibitor (Merck & Co) |
|
MKC442 |
6-benzyl-1-ethoxymethyl-5-isopropyluracil (I-EBU, Triangle Pharmaceuticals/Mitsubishi) |
|
MP-134 |
C2 symmetry-based protease inhibitor |
|
MP-167 |
C2 symmetry-based protease inhibitor |
|
nevirapine |
11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyridol[3,2-b:2',3'-e] diazepin-6-one (Boehringer Ingelheim) |
|
NNRTI |
non-nucleoside reverse transcriptase inhibitor |
|
NSC648400 |
1-benzyloxymethyl-5-ethyl-6-(alpha-pyridylthio)uracil (E-BPTU) |
|
P9941 |
[2-pyridylacetyl-IIePheAla-y(CHOH)]\sub2 (Dupont Merck) |
|
PFA |
phosphonoformate (foscarnet, Astra) |
|
PMEA |
9-(2 phosphonylmethoxyethyl)adenine (Gilead Sciences) |
|
PMPA |
(R)-9-(2-phosphonyl-methoxypropyl)adenine (Gilead Sciences) |
|
QM96521 |
A 1,1,3-trioxo-2H,4H-thieno[2,4-3][1,2,3]thiadiazine derivative (TTD) |
|
Ro 31-8959 |
hydroxyethylamine derivative HIV-1 protease inhibitor (Roche) |
|
RPI-312 |
1-[(3S)-3-(n-alpha-benzyloxycarbonyl)-l-asparginyl)-amino-2-hydroxy-4-phenyl-butyryl]-n-tert-butyl-l-proline amide (peptidyl protease inhibitor) |
|
RPR103611 |
|
|
RT |
reverse transcriptase |
|
S-2720 |
6-chloro-3,3-dimethyl-4-(isopropenyl-oxycarbonyl)-3,4-dihydro-quinoxalin-2(1H)thione |
|
SC-52151 |
hydroxyethylurea isostere protease inhibitor (Searle) |
|
SC-55389A |
hydroxyethyl-urea isostere protease inhibitor (Searle) |
|
SDF-1a |
Stromal cell-derived factor 1 a |
|
TIBO R82150 |
(+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)-imidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thione (Janssen) |
|
TIBO 82913 |
(+)-(5S)-4,5,6,7,-tetrahydro-9-chloro-5-methyl-6-(3-methyl-2-butenyl)-imidazo-[4,5,1-jk]-[1,4]benzo-diazepin-2(1H)-thione (Janssen) |
|
TSAO-m3T |
[2',5'-bis-O-(tert-butyl-dimethylsilyl)-3'-spiro-5'-(4'-amino-1',2'-oxathiole-2',2'-dioxide)]-b-D-pentofuranosyl-N3-methylthymine |
|
U-90152 |
1-[3-[(1-methylethyl)-amino]-2-pyridinyl]-4-[[5-[(methylsulphonyl)-amino]-lH-indol-2yl]carbonyl]-piperazine |
|
U-95133 |
(Alkylamino)piperidine bis(heteroaryl)piperizine analog |
|
U-104489 |
(Alkylamino)piperidine bis(heteroaryl)piperizine analog |
|
UC-040 |
thiocarboxanilide derivative (Uniroyal Chemical Co) |
|
UC |
thiocarboxanilide derivatives (Uniroyal Chemical Co) |
|
UC-781 |
N-[4-chloro-3-(3-methyl-2-butenyloxy)phenyl]-2-methyl-3-furan-carbothioamide |
|
UC-82 |
N-[4-chloro-3-(3-methyl-2-butenyloxy)phenyl]-2-methyl-3-thiophene-carbothioamide |
|
VB 11,328 |
hydroxyethyl-sulphonamide protease inhibitor (Vertex Pharmaceuticals) |
|
VX-478 |
hydroxyethylsulphonamide protease inhibitor (Vertex Pharmaceuticals) |
|
XM 323 |
cyclic urea protease inhibitor (Dupont Merck) |